endotoxin escherichia coli (E. coli) lipopolysaccharide (LPS)

BIOLOGICAL2 trials

Sponsors

Boehringer Ingelheim, University Hospital, Linkoeping

Conditions

HealthyInflammationInflammation Biomarkers

Phase 1

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BI 653048 BS H3PO4 Capsule Assessing Endotoxin-induced Inflammatory Response in Healthy Male Subjects

CompletedNCT02224105

Boehringer IngelheimHealthy

Start: 2010-03-31Updated: 2014-08-25

Unknown Phase

Individual Differences in Acute Response to Experimental Inflammation: Microcirculatory Changes and Psychological Predictors

Enrolling by invitationNCT06618716

University Hospital, LinkoepingInflammation, Inflammation Biomarkers

Start: 2024-09-05End: 2029-12-31Target: 25Updated: 2024-10-01

Related Papers

Clinical profile of the functionally selective glucocorticoid receptor agonist BI 653048 in healthy male subjects.

2019-04-095 citations